About this trial
The goal of this clinical trial is to evaluate the effectiveness of the use of a novel crosslinking hyaluronan hydrogel on the prevention of the adhesion occurrence after anterior talofibular ligament repair surgery. With applying crosslinking hyaluronan hydrogel, the range of motion (ROM) of the ankle is expected to be better than sham group.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial design
Parallel
Treatments tested in this trial
DEFEHERE Absorbable Adhesion Barrier
DeviceDEFEHERE Absorbable Adhesion Barrier, 1.0 mL/syringe
Sham (No Treatment)
Deviceconventional therapy without using any antiadhesion product
Treatment groups
Trial outcomes
Primary outcomes
Range of Motion (ROM)
Measure the range of plantar flexion, dorsiflexion, inversion, and eversion of the ankle.
Secondary outcomes
Range of Motion (ROM)
Measure the range of plantar flexion, dorsiflexion, inversion, and eversion of the ankle.
Anterior Talar Translation (ATT)
On the sagittal plane, the talus below the tibia will be pulled forward to test the integrity of the anterior talofibular ligament.
Visual Analogue Scale (VAS) for pain
The VAS scale uses a 10 cm line labelled at '0' with 'no pain' and '10' with 'worst pain'
Cumberland Ankle Instability Tool (CAIT) questionnaire
The Cumberland Ankle Instability Tool (CAIT) is a 9-item 30-point scale that measures the severity of functional ankle instability.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.